<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260907070953N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-11-22</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Comparison of Otago and Dynamic Neuromuscular Stabilization (DNS) exercises on elderly</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of two training methods Otago and dynamic neuromuscular stabilization on kinetic, spatio-temporal parameters of gait and balance performance in elderly women with a history of falls</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-11-30</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>72</target_size>
      <recruitment_status>Pending</recruitment_status>
      <url>https://irct.ir/trial/94358</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Other design features: A three-arm parallel-group randomized controlled trial with a follow-up assessment period, Randomization description: Participants will be randomized into three groups (Otago, DNS and Control) using a block randomization method with a block size of 6 to ensure equal group sizes throughout the recruitment process. The unit of randomization is the individual. Computer software ( SPSS, version 26) will be used to generate the random allocation sequence. Allocation concealment will be strictly maintained using sequentially numbered, opaque, sealed envelopes (SNOSE), which will be prepared by an independent researcher who is not involved in the participants’ recruitment, assessment, or intervention process. The envelopes will be opened only after the participant is enrolled in the study and baseline assessments are completed.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Elderly women with a history of falls.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Otago. The group receives a structured Otago program for 8 weeks, 3 sessions per week, each lasting approximately 45 to 60 minutes, under full supervision. Each session includes a warm-up, 17 specific muscle strengthening and balance exercises (5 strengthening exercises for lower-limb muscles and 12 balance exercises), and a cool-down. Strengthening exercises are performed using ankle weights and are progressed gradually. Balance exercises include static and dynamic patterns such as standing on one leg, heel-toe walking, and sideways walking, performed at different levels of difficulty. In addition to the exercises, a walking program is also included. All sessions are held by trained instructors in a gym environment. Intervention 2: Intervention group: DNS,: Dynamic Neuromuscular Stabilization (DNS). This group receives functional DNS exercises for 8 weeks, 3 sessions per week, each lasting approximately 45 to 60 minutes, under full supervision. Each session includes a warm-up, specific DNS exercises, and a cool-down. The exercises emphasize generating and maintaining intra-abdominal pressure, core stability, correct activation of trunk and limb muscles, and retraining developmental movement patterns. Exercises are progressed gradually from simple stabilizing patterns to more complex functional patterns. All sessions are held by trained instructors in a gym environment. Intervention 3: Control group: During the 8-week study period, participants receive no structured exercise intervention and maintain only their routine daily activities. They are asked not to participate in any new structured exercise or rehabilitation program during this period. Outcome assessments are performed at the same time points as the intervention groups (baseline, week 8, and week 12).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is Individual participant data will not be shared because the dataset contains sensitive health and biomechanical information from a small sample of elderly women, and the study team does not have the infrastructure or resources to manage secure de-identification, access control, and data use agreements for IPD sharing. To protect participant confidentiality, only aggregated results will be reported in publications, while the study protocol, statistical analysis plan, analytic code, and data dictionary will be shared as described in the data sharing plan.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ali Fatahi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Sohanak, Artesh Boulevard, Qaem Square, Khandan Street, Salman Street, Velayat University Complex</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1955847781</zip>
        <telephone>+98 21 7368 1317</telephone>
        <email>alifatahi@iau.ac.ir</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Somayeh Mehrlatifan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tehran, Artesh Highway, Sohanak, Velayat Campus, Islamic Azad University, Central Tehran Branch</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۹۵۵۸۴۷۷۸۱</zip>
        <telephone>+98 21 2292 1372</telephone>
        <email>s.mehrlatifan@iau.ac.ir</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Female gender and age range of 65 to 85 years;
 A history of at least one fall in the past 12 months (based on a fall history questionnaire, self-report, and regular telephone follow-up over the year);
 Ability to walk independently for a distance of at least 10 meters without the assistance of a fixed assistive device;
 Absence of acute neurological disorders (e.g., stroke, Parkinson’s disease, spinal cord injury) or active musculoskeletal disorders in the lower extremities;
 Absence of severe chronic lower extremity pain that would prevent exercise performance;
 Absence of severe untreated visual and vestibular disorders;
 Providing written informed consent to participate in the study.</inclusion_criteria>
      <agemin>65 years</agemin>
      <agemax>85 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Excessive absence from training sessions (more than 20% of total sessions or three consecutive sessions);
 Injury during the exercise intervention that makes continued participation impossible;
 Significant changes in medication regimens affecting the neuromuscular system (e.g., sedatives or newly prescribed antihypertensive medications that affect balance);
 Hospitalization or occurrence of an acute illness during the study;
 Experiencing a re-fall with serious injury during the evaluation intervals;
 Initiation of concurrent participation in another exercise or rehabilitation program (confounding training);
 Participant’s request to withdraw from the study.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Otago. The group receives a structured Otago program for 8 weeks, 3 sessions per week, each lasting approximately 45 to 60 minutes, under full supervision. Each session includes a warm-up, 17 specific muscle strengthening and balance exercises (5 strengthening exercises for lower-limb muscles and 12 balance exercises), and a cool-down. Strengthening exercises are performed using ankle weights and are progressed gradually. Balance exercises include static and dynamic patterns such as standing on one leg, heel-toe walking, and sideways walking, performed at different levels of difficulty. In addition to the exercises, a walking program is also included. All sessions are held by trained instructors in a gym environment.</i_keyword>
      <i_keyword>Intervention group: DNS,: Dynamic Neuromuscular Stabilization (DNS). This group receives functional DNS exercises for 8 weeks, 3 sessions per week, each lasting approximately 45 to 60 minutes, under full supervision. Each session includes a warm-up, specific DNS exercises, and a cool-down. The exercises emphasize generating and maintaining intra-abdominal pressure, core stability, correct activation of trunk and limb muscles, and retraining developmental movement patterns. Exercises are progressed gradually from simple stabilizing patterns to more complex functional patterns. All sessions are held by trained instructors in a gym environment.</i_keyword>
      <i_keyword>Control group: During the 8-week study period, participants receive no structured exercise intervention and maintain only their routine daily activities. They are asked not to participate in any new structured exercise or rehabilitation program during this period. Outcome assessments are performed at the same time points as the intervention groups (baseline, week 8, and week 12).</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Balance performance (Berg Balance Scale score). Timepoint: Will be performed at three time points: 1) baseline (before the start of the intervention); 2) immediately after the end of the 8-week intervention (week 8); 3) after 4 weeks without training (follow-up, week 12) to assess the durability of the effect. Method of measurement: The test requires a chair without armrests, a stopwatch, a ruler, and a step stool. The 14 tasks include:Sitting to standingStanding unsupported (for 2 minutes)Sitting unsupported (for 2 minutes)Standing to sittingTransfers (from chair to bed and back)Standing with eyes closed (10 seconds)Standing with feet togetherReaching forward with outstretched arm while standingRetrieving an object from the floor from a standing positionTurning to look behind over the left and right shoulders while standingTurning 360 degreesPlacing alternate foot on step or stool while standing unsupportedStanding unsupported with one foot in front (Tandem stance)Standing on one legScoring:0 = Requires maximum assistance4 = Independent and safeInterpretation: Scores of 41-56 indicate good/independent balance; 21-40 indicate medium balance/requiring assistance; 0-20 indicate poor balance.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Spatial-temporal gait parameters:These are the unique gait characteristics of each individual, which are assessed using laboratory instruments. Timepoint: Secondary outcomes will be measured at three time points: baseline (before the start of the intervention), immediately after the end of the 8-week intervention (week 8), and after a 4-week follow-up without training (week 12). Method of measurement: Spatio-temporal gait parameters are measured using an instrumented treadmill with embedded force plates. The individual performs the two-minute Gait-treadmill walking test as follows: The participant walks on the treadmill for two minutes at a self-selected, preferred speed. This trial is performed three times, and the average of the three trials is recorded as the test score.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-01-08</approval_date>
        <contact_name>Research Ethics Committees of Islamic Azad University-Central Tehran Branch</contact_name>
        <contact_address>Tehran, Artesh Highway, Sohanak, Velayat Campus, Islamic Azad University, Central Tehran Branch Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
